Regeneron Pharmaceuticals, Inc. (REGN)
Regeneron Pharmaceuticals, Inc. Net Income
| Dec'04 | Dec'05 | Dec'06 | Dec'07 | Dec'08 | Dec'09 | Dec'10 | Dec'11 | Dec'12 | Dec'13 | Dec'14 | Dec'15 | Dec'16 | Dec'17 | Dec'18 | Dec'19 | Dec'20 | Dec'21 | Dec'22 | Dec'23 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Net Income | $41.7M | ($95.4M) | ($102.3M) | ($105.6M) | ($82.7M) | ($67.8M) | ($104.5M) | ($221.8M) | $750.3M | $424.4M | $348.1M | $636.1M | $895.5M | $1,198.5M | $2,444.4M | $2,115.8M | $3,513.2M | $8,075.3M | $4,338.4M | $3,953.6M |
Regeneron Pharmaceuticals, Inc. (REGN) Net Income comparison analysis
REGN key stats
Discover more Stock Ideas
Undervalued stocks right now
Discover the top 20 best undervalued stocks to buy for Jan 2025, listed on the Nasdaq or NYSE.
Undervalued growth stocks
Discover the top 20 best undervalued large-cap growth stocks to buy for Jan 2025, listed on the Nasdaq or NYSE.
Undervalued dividend stocks
Discover the top 20 best undervalued high-yield dividend stock that offers both growth potential and attractive dividend returns for Jan 2025.
investors
worldwide
FAQ
1) What is Regeneron Pharmaceuticals, Inc.'s Net Income?
As of today, Regeneron Pharmaceuticals, Inc.'s last 12-month Net Income is $4,654.5M, based on the financial report for Sep 30, 2024 (Q3 2024).
2) What is Regeneron Pharmaceuticals, Inc.'s Net Income growth rate?
Over the last year, Regeneron Pharmaceuticals, Inc.'s Net Income growth was 16.6%. The average annual Net Income growth rates for Regeneron Pharmaceuticals, Inc. have been 5.1% over the past three years, 16.8% over the past five years.
3) Is Regeneron Pharmaceuticals, Inc.'s Net Income growth rate Good?
Over the last year, Regeneron Pharmaceuticals, Inc.'s Net Income growth was 16.6%, which is higher than industry growth of (0.1%). It indicates that Regeneron Pharmaceuticals, Inc.'s Net Income growth is Good.